{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:27:43Z","timestamp":1759336063932,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.peptides.2022.170922","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T11:13:15Z","timestamp":1670411595000},"page":"170922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prothymosin \u03b1-derived hexapeptide prevents the brain damage and sequelae due to ischemia-hemorrhage"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8002-0137","authenticated-orcid":false,"given":"Hiroshi","family":"Ueda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.peptides.2022.170922_bib1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1248\/bpb.27.950","article-title":"Cell death mode switch from necrosis to apoptosis in brain","volume":"27","author":"Ueda","year":"2004","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.peptides.2022.170922_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neuroscience.2021.06.023","article-title":"Apoptosis, autophagy, necrosis and their multi galore crosstalk in neurodegeneration","volume":"469","author":"Saleem","year":"2021","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.peptides.2022.170922_bib3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.cell.2018.03.032","article-title":"The structure of the necrosome RIPK1-RIPK3 core, a human hetero-amyloid signaling complex","volume":"173","author":"Mompean","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.peptides.2022.170922_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.16","article-title":"Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death","volume":"6","author":"Moriwaki","year":"2015","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.peptides.2022.170922_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1023\/A:1026375225275","article-title":"Low-density induced apoptosis of cortical neurons is inhibited by serum factors","volume":"18","author":"Sasaki","year":"1998","journal-title":"Cell Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.peptides.2022.170922_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1083\/jcb.200608022","article-title":"Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures","volume":"176","author":"Ueda","year":"2007","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.peptides.2022.170922_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/cdd.2008.159","article-title":"Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition","volume":"16","author":"Fujita","year":"2009","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.peptides.2022.170922_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/jnc.12262","article-title":"Retinal cell type-specific prevention of ischemia-induced damages by LPS-TLR4 signaling through microglia","volume":"126","author":"Halder","year":"2013","journal-title":"J. Neurochem"},{"issue":"6","key":"10.1016\/j.peptides.2022.170922_bib9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/jnc.13356","article-title":"Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina","volume":"135","author":"Halder","year":"2015","journal-title":"J. Neurochem"},{"issue":"2","key":"10.1016\/j.peptides.2022.170922_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jphs.2020.01.008","article-title":"Experimental evidence for the involvement of F0\/F1 ATPase and subsequent P2Y12 receptor activation in prothymosin alpha-induced protection of retinal ischemic damage","volume":"143","author":"Halder","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.peptides.2022.170922_bib11","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.cdd.4402189","article-title":"Prothymosin-alpha1 prevents necrosis and apoptosis following stroke","volume":"14","author":"Fujita","year":"2007","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.peptides.2022.170922_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jphs.2016.05.006","article-title":"Neuroprotective DAMPs member prothymosin alpha has additional beneficial actions against cerebral ischemia-induced vascular damages","volume":"132","author":"Maeda","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"Pt 12","key":"10.1016\/j.peptides.2022.170922_bib13","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/brain\/awt201","article-title":"The exact science of stroke thrombolysis and the quiet art of patient selection","volume":"136","author":"Balami","year":"2013","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.peptides.2022.170922_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1941874415583116","article-title":"Intravenous thrombolysis for acute ischemic stroke within 3\u2009h versus between 3 and 4.5\u2009h of symptom onset","volume":"5","author":"Cheng","year":"2015","journal-title":"Neurohospitalist"},{"issue":"6","key":"10.1016\/j.peptides.2022.170922_bib15","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1161\/STROKEAHA.108.544171","article-title":"4.5\u2009h: the new time window for tissue plasminogen activator in stroke","volume":"40","author":"Davis","year":"2009","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.peptides.2022.170922_bib16","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/STROKEAHA.111.645986","article-title":"Eligibility for Intravenous recombinant tissue-type plasminogen activator within a population: the effect of the european cooperative acute stroke study (ECASS) III trial","volume":"43","author":"de Los Rios la Rosa","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.peptides.2022.170922_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fncel.2016.00002","article-title":"A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia","volume":"10","author":"Suzuki","year":"2016","journal-title":"Front Cell Neurosci."},{"issue":"6","key":"10.1016\/j.peptides.2022.170922_bib18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/jnc.14858","article-title":"Prothymosin alpha and its mimetic hexapeptide improve delayed tissue plasminogen activator-induced brain damage following cerebral ischemia","volume":"153","author":"Halder","year":"2020","journal-title":"J. Neurochem"},{"issue":"5","key":"10.1016\/j.peptides.2022.170922_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jnc.12132","article-title":"Novel neuroprotective action of prothymosin alpha-derived peptide against retinal and brain ischemic damages","volume":"125","author":"Halder","year":"2013","journal-title":"J. Neurochem"},{"key":"10.1016\/j.peptides.2022.170922_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.peptides.2013.02.022","article-title":"Therapeutic benefits of 9-amino acid peptide derived from prothymosin alpha against ischemic damages","volume":"43","author":"Halder","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2022.170922_bib21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuroscience.2016.01.007","article-title":"Neuroprotective impact of prothymosin alpha-derived hexapeptide against retinal ischemia-reperfusion","volume":"318","author":"Ueda","year":"2016","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.peptides.2022.170922_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuroscience.2009.03.042","article-title":"Development and characterization of a hemorrhagic rat model of central post-stroke pain","volume":"161","author":"Wasserman","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2022.170922_bib23","article-title":"Lysophosphatidic acid LPA1 and LPA3 receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice","volume":"5","author":"Ueda","year":"2019","journal-title":"Neurobiol. Pain."},{"key":"10.1016\/j.peptides.2022.170922_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170265","article-title":"Beneficial actions of prothymosin alpha-mimetic hexapeptide on central post-stroke pain, reduced social activity, learning-deficit and depression following cerebral ischemia in mice","volume":"126","author":"Sasaki","year":"2020","journal-title":"Peptides"},{"issue":"sup1","key":"10.1016\/j.peptides.2022.170922_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/14712598.2018.1454427","article-title":"Ecto-F(0)\/F(1) ATPase as a novel candidate of prothymosin alpha receptor","volume":"18","author":"Ueda","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.peptides.2022.170922_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1096\/fj.10-169417","article-title":"Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling","volume":"25","author":"Freeman","year":"2011","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.peptides.2022.170922_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41467-020-20361-3","article-title":"Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner","volume":"12","author":"Gladka","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.peptides.2022.170922_bib28","first-page":"187","article-title":"Prothymosin alpha gene transfer modulates myocardial remodeling after ischemia-reperfusion injury","volume":"38","author":"Shiau","year":"2022","journal-title":"Acta Cardiol. Sin."},{"issue":"3","key":"10.1016\/j.peptides.2022.170922_bib29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/path.4664","article-title":"Over-expression of prothymosin-alpha antagonizes TGFbeta signalling to promote the development of emphysema","volume":"238","author":"Su","year":"2016","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.peptides.2022.170922_bib30","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/cdd.2010.52","article-title":"Stress-induced non-vesicular release of prothymosin-alpha initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage","volume":"17","author":"Matsunaga","year":"2010","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.peptides.2022.170922_bib31","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1038\/s41598-018-38065-6","article-title":"Critical functionality effects from storage temperature on human induced pluripotent stem cell-derived retinal pigment epithelium cell suspensions","volume":"9","author":"Kitahata","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.peptides.2022.170922_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10157-019-01843-1","article-title":"Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injury","volume":"24","author":"Torigoe","year":"2020","journal-title":"Clin. Exp. Nephrol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978122001887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978122001887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:33:59Z","timestamp":1759311239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978122001887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":32,"alternative-id":["S0196978122001887"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2022.170922","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prothymosin \u03b1-derived hexapeptide prevents the brain damage and sequelae due to ischemia-hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2022.170922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170922"}}